You are not authorized to access this page.
Search Within

Jennifer Wheler

Formats
  1. Meeting Abstract (8)
  2. Journal Article (2)
  3. Book Whole (1)
Groups
  1. Breast Medicine Service (10)
  2. Department of Medicine (10)
  3. Solid Tumor Oncology Division (10)
  4. Survivorship Research (9)
  5. GSK Faculty (3)
  6. Genitourinary Oncology Service (3)

More Groups

People
  1. Clifford Hudis (6)
  2. David Solit (3)
  3. Shanu Modi (3)
  4. Ashley Doane (2)
  5. Michael Danso (2)
  6. Monica Fornier (2)

More People

Years
  1. 2007 (2)
  2. 2006 (6)
  3. 2005 (3)
Publications
  1. Journal of Clinical Oncology (5)
  2. Breast Cancer Research and Treatment (2)
  3. Cancer Research (1)
  4. Hematology and oncology pearls (1)
  5. International Journal of Biological Markers (1)
  6. Seminars in Oncology (1)
Publishers
  1. American Society of Clinical Oncology (5)
  2. Springer (2)
  3. American Association for Cancer Research (1)
  4. Elsevier Inc. (1)
  5. Mosby Elsevier (1)
  6. Wichtig Editore (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Decline in serum HER-2/neu predicts response to trastuzumab-based therapy
    Meeting Abstract

    Ali, S. M.; Brault, D.; Brown-Shimer, S.; Carney, W.; Esteva, F. J.; Fornier, M.; Gligorov, J.; Hamer, P.; Harris, L.; KoĢˆstler, W. J.; more...
    International Journal of Biological Markers (2007)

    Fulltext@MSK | Save
  • Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I dose-escalation study
    Journal Article

    Modi, S.; Stopeck, A. T.; Gordon, M. S.; Mendelson, D.; Solit, D. B.; Bagatell, R.; Ma, W.; Wheler, J.; Rosen, N.; Norton, L.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I dose escalating trial of KOS-953 (heat shock protein 90 inhibitor) and trastuzumab (T)
    Meeting Abstract

    Modi, S.; Stopeck, A. T.; Gordon, M. S.; Solit, D.; Bagatell, R.; Ma, W.; Wheler, J.; Cropp, G. F.; Rosen, N.; Johnson, R. G. Jr; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • High expression of the chemokine receptor CXCR4 is associated with estrogen receptor-negative breast cancer
    Meeting Abstract

    Wheler, J. J.; Doane, A. S.; Linkov, I.; Hudis, C. A.; Gerald, W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase I trial of KOS-953, a heat shock protein 90 inhibitor, and trastuzumab (T)
    Meeting Abstract

    Modi, S.; Stopeck, A.; Gordon, M. S.; Solit, D.; Ma, W.; Wheler, J.; Cropp, G.; Johnson, R. G.; Hannah, A. L.; Hudis, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Distinct PIK3CA mutation profiles in estrogen receptor (ER) negative breast cancer (BC) subsets
    Meeting Abstract

    Doane, A. S.; Danso, M.; Lal, P.; Donaton, M.; Wheler, J.; Moynahan, M.; Zhang, L.; Hudis, C.; Gerald, W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Serum HER-2/neu decline predicts improved response to trastuzumab-based therapy in patients with normal and elevated baseline serum HER-2/neu levels
    Meeting Abstract

    Ali, S. M.; Brault, D.; Brown-Shimer, S.; Carney, W.; Esteva, F. J.; Fornier, M.; Gligorov, J.; Hamer, P.; Harris, L.; Leitzel, K.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: Evidence and ongoing controversy
    Journal Article

    Wheler, J.; Johnson, M.; Seidman, A.
    Seminars in Oncology (2006)

    Fulltext@MSK | Save
  • Hematology and oncology pearls
    Book Whole


    Mosby Elsevier (2005)

    Fulltext@MSK | Save
  • Female sexual dysfunction and changes in hormonal levels in patients with early breast cancer on anti-estrogen therapy
    Meeting Abstract

    Amsterdam, A. D.; Wheler, J.; Hudis, C.; Krychman, M. L.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save